|
|
Volumn 10, Issue 3, 2004, Pages 273-278
|
|
The immunotherapies markets, 2003-2008
|
|
Author keywords
Monoclonal antibodies; Therapeutic vaccines; Therapeutics
|
|
Indexed keywords
ADALIMUMAB;
ANTIBODY;
CANCER VACCINE;
CHIMERIC ANTIBODY;
IMMUNOMODULATING AGENT;
INFLIXIMAB;
M VAX;
MELACINE;
MONOCLONAL ANTIBODY;
PALIVIZUMAB;
PROVENGE;
RECOMBINANT PROTEIN;
RITUXIMAB;
TRASTUZUMAB;
VACCINE;
ANTIBODY SCREENING;
ARTICLE;
COMMERCIAL PHENOMENA;
DRUG INDUSTRY;
DRUG MARKETING;
FINANCIAL MANAGEMENT;
FORECASTING;
|
|
EID: 2542499672
PISSN: 14628732
EISSN: None
Source Type: Journal
DOI: 10.1057/palgrave.jcb.3040083 Document Type: Article |
|
Times cited : (2)
|
|
References (0)
|
